Ex vivo T-cell depletion with the monoclonal antibody Campath-1 plus human complement effectively prevents acute graft-versus-host disease in allogeneic bone marrow transplantation.

We have developed a rapid and simple procedure for the elimination of mature T-cells from the donor marrow using a single incubation with the monoclonal antibody Campath-1 and donor complement. This resulted in a reduction of T-cell contamination to a mean of 1%. This regimen reduced the incidence o...

Täydet tiedot

Bibliografiset tiedot
Päätekijät: Heit, W, Bunjes, D, Wiesneth, M, Schmeiser, T, Arnold, R, Hale, G, Waldmann, H, Heimpel, H
Aineistotyyppi: Journal article
Kieli:English
Julkaistu: 1986
_version_ 1826280217843335168
author Heit, W
Bunjes, D
Wiesneth, M
Schmeiser, T
Arnold, R
Hale, G
Waldmann, H
Heimpel, H
author_facet Heit, W
Bunjes, D
Wiesneth, M
Schmeiser, T
Arnold, R
Hale, G
Waldmann, H
Heimpel, H
author_sort Heit, W
collection OXFORD
description We have developed a rapid and simple procedure for the elimination of mature T-cells from the donor marrow using a single incubation with the monoclonal antibody Campath-1 and donor complement. This resulted in a reduction of T-cell contamination to a mean of 1%. This regimen reduced the incidence of acute graft-versus-host disease significantly in 21 consecutive bone marrow grafts in 18 patients with leukaemia and non-Hodgkin's lymphoma. Purging was responsible for an increased incidence of graft rejection in HLA-identical transplants (13%).
first_indexed 2024-03-07T00:10:24Z
format Journal article
id oxford-uuid:7907351c-d7dd-41eb-9954-b725110be2e1
institution University of Oxford
language English
last_indexed 2024-03-07T00:10:24Z
publishDate 1986
record_format dspace
spelling oxford-uuid:7907351c-d7dd-41eb-9954-b725110be2e12022-03-26T20:34:43ZEx vivo T-cell depletion with the monoclonal antibody Campath-1 plus human complement effectively prevents acute graft-versus-host disease in allogeneic bone marrow transplantation.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:7907351c-d7dd-41eb-9954-b725110be2e1EnglishSymplectic Elements at Oxford1986Heit, WBunjes, DWiesneth, MSchmeiser, TArnold, RHale, GWaldmann, HHeimpel, HWe have developed a rapid and simple procedure for the elimination of mature T-cells from the donor marrow using a single incubation with the monoclonal antibody Campath-1 and donor complement. This resulted in a reduction of T-cell contamination to a mean of 1%. This regimen reduced the incidence of acute graft-versus-host disease significantly in 21 consecutive bone marrow grafts in 18 patients with leukaemia and non-Hodgkin's lymphoma. Purging was responsible for an increased incidence of graft rejection in HLA-identical transplants (13%).
spellingShingle Heit, W
Bunjes, D
Wiesneth, M
Schmeiser, T
Arnold, R
Hale, G
Waldmann, H
Heimpel, H
Ex vivo T-cell depletion with the monoclonal antibody Campath-1 plus human complement effectively prevents acute graft-versus-host disease in allogeneic bone marrow transplantation.
title Ex vivo T-cell depletion with the monoclonal antibody Campath-1 plus human complement effectively prevents acute graft-versus-host disease in allogeneic bone marrow transplantation.
title_full Ex vivo T-cell depletion with the monoclonal antibody Campath-1 plus human complement effectively prevents acute graft-versus-host disease in allogeneic bone marrow transplantation.
title_fullStr Ex vivo T-cell depletion with the monoclonal antibody Campath-1 plus human complement effectively prevents acute graft-versus-host disease in allogeneic bone marrow transplantation.
title_full_unstemmed Ex vivo T-cell depletion with the monoclonal antibody Campath-1 plus human complement effectively prevents acute graft-versus-host disease in allogeneic bone marrow transplantation.
title_short Ex vivo T-cell depletion with the monoclonal antibody Campath-1 plus human complement effectively prevents acute graft-versus-host disease in allogeneic bone marrow transplantation.
title_sort ex vivo t cell depletion with the monoclonal antibody campath 1 plus human complement effectively prevents acute graft versus host disease in allogeneic bone marrow transplantation
work_keys_str_mv AT heitw exvivotcelldepletionwiththemonoclonalantibodycampath1plushumancomplementeffectivelypreventsacutegraftversushostdiseaseinallogeneicbonemarrowtransplantation
AT bunjesd exvivotcelldepletionwiththemonoclonalantibodycampath1plushumancomplementeffectivelypreventsacutegraftversushostdiseaseinallogeneicbonemarrowtransplantation
AT wiesnethm exvivotcelldepletionwiththemonoclonalantibodycampath1plushumancomplementeffectivelypreventsacutegraftversushostdiseaseinallogeneicbonemarrowtransplantation
AT schmeisert exvivotcelldepletionwiththemonoclonalantibodycampath1plushumancomplementeffectivelypreventsacutegraftversushostdiseaseinallogeneicbonemarrowtransplantation
AT arnoldr exvivotcelldepletionwiththemonoclonalantibodycampath1plushumancomplementeffectivelypreventsacutegraftversushostdiseaseinallogeneicbonemarrowtransplantation
AT haleg exvivotcelldepletionwiththemonoclonalantibodycampath1plushumancomplementeffectivelypreventsacutegraftversushostdiseaseinallogeneicbonemarrowtransplantation
AT waldmannh exvivotcelldepletionwiththemonoclonalantibodycampath1plushumancomplementeffectivelypreventsacutegraftversushostdiseaseinallogeneicbonemarrowtransplantation
AT heimpelh exvivotcelldepletionwiththemonoclonalantibodycampath1plushumancomplementeffectivelypreventsacutegraftversushostdiseaseinallogeneicbonemarrowtransplantation